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In Response: The report by Mat-
tison et al. about detection of norovi-
ruses in 6% of ready-to-eat packaged 
leafy greens sampled in Ontario, Can-
ada, suggests that these products could 
be vehicles for widespread dissemina-
tion of norovirus (1). As they suggest, 
this  ﬁ   nding should lead to studies 
evaluating the potential risk from such 
contamination. In particular, prospec-
tive attempts to identify whether these 
strains may be associated with com-
munity outbreaks are necessary. How-
ever, the primary norovirus genotype 
identiﬁ  ed in the leafy greens samples 
(GI) is not the norovirus that has pri-
marily caused human illness in recent 
years (GII).
Ready-to-eat packaged leafy 
greens are widely eaten. One third of 
respondents to the 2002 FoodNet Pop-
ulation Survey reported eating pre-
packaged salad in the week before in-
terview (2). In the absence of evidence 
linking this contamination to norovirus 
outbreaks, it is premature for consum-
ers to change how they handle or eat 
ready-to-eat packaged leafy greens.
The authors provide data on the 
apparent viral loads they observed and 
cite data to suggest that washing and 
disinfecting produce before eating it 
could reduce viral loads below the lev-
el of an infectious dose. However, the 
Food and Drug Administration does 
not recommend rewashing prewashed 
produce and does not recommend 
washing fresh produce with soap, de-
tergent, or commercial produce wash-
es (3). Because the products sampled 
in the study by Mattison et al. were 
prewashed, whether washing them 
would further reduce viral loads is not 
clear. In addition, rewashing ready-to-
eat produce creates a potential risk for 
cross-contamination of the produce in 
consumers’ kitchens. Soap, detergents, 
or sanitizers could leave potentially 
harmful residues if rewashed produce 
is not thoroughly rinsed. These poten-
tial risks need to be weighed against 
the uncertain potential beneﬁ  ts of re-
washing ready-to-eat packaged leafy 
greens. Given the ubiquity of these 
products, any change in recommended 
handling practices could have far-
reaching consequences.
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The Persistence of 
Inﬂ  uenza Infection
To the Editor: The report by Pin-
sky et al. (1) is interesting, but it raises 
some major questions. The ﬁ  nding 
of inﬂ  uenza virus in stool is not new 
(2). Of more interest is their statement 
regarding the prolonged shedding of 
inﬂ   uenza virus in the stool (for >2 
months) and respiratory secretions 
(for >1.5 years). How frequently were 
respiratory samples collected and 
tested to conﬁ  rm that the same virus 
was shed for these periods in these 
samples? Inﬂ   uenza virus, like most 
other acute respiratory viruses, typi-
cally does not cause long-term latent 
or persistent infections in humans. 
The authors need to exclude the pos-
sibility of frequent reinfection with 
contemporary circulating seasonal he-
magglutinin 1 (H1) inﬂ  uenza viruses. 
However, they do not provide any data 
to this effect.
Currently, with the wider avail-
ability and more stringent expectations 
of modern molecular techniques, such 
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data might be obtained by collecting 
and sequencing several genes (ideally 
full genomes) from contemporary cir-
culating seasonal H1 viruses and com-
paring them, phylogenetically, with 
the virus shed, contemporaneously, 
from the child, at monthly intervals, 
for example (if the child tolerates this 
testing). Even with this testing fre-
quency, several inﬂ  uenza infection ep-
isodes may go undetected. Although 
the child’s virus, if it truly persists, 
may undergo some minor host-in-
duced mutations, new infections with 
seasonal H1 viruses will likely dem-
onstrate a greater, sudden sequence 
variability, which enables them to be 
relatively easily distinguished from 
the more minor, gradually accumu-
lated mutations that can be seen in a 
persisting infection (3).
Second, ribavirin is not recom-
mended for treating inﬂ  uenza infection 
(4,5). Can the authors explain why this 
child was taking ribavirin for inﬂ  u-
enza infection, and how often was his 
condition treated with this drug dur-
ing the 1.5 years when inﬂ  uenza H1 
was shed? Was his treatment regimen 
eventually changed? Currently, the 
recommended treatment for inﬂ  uenza 
is with the neuraminidase inhibitors 
(oseltamivir, zanamivir), which have a 
much safer adverse effect proﬁ  le, and 
their effectiveness has been shown to 
be cost-effective (5).
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In Response: We appreciate Dr 
Tang’s insightful letter (1) regarding 
our article (2) and are encouraged that 
this case report may have evoked in-
creased interest in the phylogeny of 
the inﬂ  uenza sequences obtained dur-
ing this patient’s longstanding illness. 
We were acutely aware that we had 
not provided evidence that it was in-
deed the same inﬂ  uenza A virus found 
in these samples. Even though we 
proposed sequencing studies in the ar-
ticle’s discussion section, in hindsight, 
we should have further expanded the 
discussion to include the points Dr 
Tang raises. At that time, however, 
we made a conscious decision not to 
include sequencing data in the manu-
script for the following reasons.
First, we believed that ﬁ  nding 
that inﬂ  uenza A virus could be iso-
lated from stool needed to be rapidly 
disseminated during the pandemic to 
reinforce awareness of the potential 
risk of acquiring inﬂ  uenza A infection 
through this source. During the sum-
mer of 2009, when we wrote this arti-
cle, only inﬂ  uenza A (H5N1) had been 
reported to be culturable from human 
stool (3). Viral nucleic acids of season-
al inﬂ  uenza A had been demonstrated 
in stool in several studies (4–6), but of 
course, identiﬁ  cation of viral nucleic 
acids remains an imperfect correlate to 
the presence of infectious virus.
Second, we considered the time, 
personnel, and funding required for 
a viral sequencing project of the type 
suggested and determined that we 
should attempt this as a follow-up 
study. Samples were obtained from the 
patient nearly every other week for >2 
years, providing valuable data to further 
investigate this important question.
Dr Tang makes an addditional 
point regarding the use of ribavirin to 
treat the patient’s condition. As labo-
ratorians, we had similar questions 
and never found satisfactory answers. 
The patient did eventually receive os-
eltamivir, but this occurred >4 months 
after his last positive inﬂ  uenza A test 
result. The antiviral drug course was 
given empirically after the patient was 
admitted to the pediatric intensive 
care unit with fever and mental status 
changes, which were ultimately deter-
mined to be due to coagulase-negative 
staphylococcal septicemia.
Benjamin Pinsky 
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etymologia etymologia
Baylisascaris
[ba''lis-as'kə-ris]
From the Greek term for intestinal worms, askaris. This genus of nematodes was named after H.A. Baylis, a 
parasitologist at the British Museum of Natural History, London, who studied these organisms in the 1920s and 
1930s. The most common cause of baylisascariasis in humans and animals is infection with the roundworm 
Baylisascaris procyonis, which takes its name from Procyon, a genus of  raccoons. The species was ﬁ  rst isolated 
from raccoons in the New York Zoological Park in 1931.
Source:  Gavin PJ, Kazacos KR, Shulman ST. Baylisascariasis. Clin Microbiol Rev. 2005;18:703–18. PMID: 16223954 